Lawrence Steinman

Publication Details

  • PROSPECTS FOR SPECIFIC IMMUNOTHERAPY IN MYASTHENIA-GRAVIS FASEB JOURNAL Steinman, L., Mantegazza, R. 1990; 4 (10): 2726-2731

    Abstract:

    Myasthenia gravis is an autoimmune disease resulting from a breakdown in T and B cell tolerance to acetylcholine receptor (AChR). Autoantibodies to AChR mediate the disease. Recent advances in experimental immunotherapy of autoimmune disease provide several possibilities for specific intervention in this well-characterized condition.

    View details for Web of Science ID A1990DP78300007

    View details for PubMedID 2197152

Stanford Medicine Resources:

Footer Links: